U2OS

U2OS
Name	U2OS
Other names	Human osteosarcoma cell line
Origin	University of Texas MD Anderson Cancer Center?
Species	Homo sapiens
Tissue	bone
Disease	osteosarcoma
Sex	Female
Morphology	Epithelial-like
Established	1964
Karyotype	Aneuploid
Repository	American Type Culture Collection

U2OS U2OS is a widely used human osteosarcoma cell line derived from a tumor of a young adult. It serves as a model system in laboratories associated with institutions such as Cold Spring Harbor Laboratory, National Institutes of Health, and EMBL for studies involving cancer research, cell cycle regulation, DNA damage response, and drug discovery. Cell biologists, molecular geneticists, and pharmacologists employ U2OS alongside other lines like HeLa, MCF-7, A549, and 293T to investigate mechanisms relevant to oncology, genomics, and proteomics.

History and origin

The line was established in the 1960s from a primary tumor of a young Caucasian female and entered wide circulation through repositories such as the American Type Culture Collection and collaborations with laboratories including MD Anderson Cancer Center and NCI. Early characterization involved cytogenetic analyses comparable to work done at Cold Spring Harbor Laboratory and karyotyping efforts in the era of Watson and Crick-era cytogenetics. The distribution and standardized use of the line were influenced by archival collections maintained by institutions like ATCC, ECACC, and research consortia at NIH.

Cell line characteristics

U2OS displays an epithelial-like morphology in monolayer culture and grows adherently on plasticware used across facilities such as Thermo Fisher Scientific and Corning. It is female in origin and exhibits an aneuploid and complex karyotype similar to other cancer-derived lines like Saos-2 and MG-63. U2OS expresses markers and pathways frequently interrogated alongside p53, Rb pathway components, and cyclin-dependent kinases; experiments often reference controls such as HEK293 and HeLa cells. Its doubling time and plating efficiency are routinely benchmarked in publications appearing in journals like Nature, Cell, and Science.

Applications in research

Researchers use U2OS extensively for studies of the DNA damage response, including assays for γH2AX foci formation and recruitment of proteins such as BRCA1, RAD51, and ATM. It is a preferred host for investigating cell cycle checkpoints involving p21, cyclin A, and CDC2; studies often contrast findings with data from HCT116 or RPE-1 lines. U2OS has been employed in high-content screening platforms developed by groups at Broad Institute and Sanger Institute for chemical-genetic interaction mapping and small-molecule screening. Functional genomics techniques—RNA interference pioneered by teams at Whitehead Institute and CRISPR-Cas9 workflows refined at MIT and Harvard—use U2OS to model gene knockdown and knockout effects on apoptosis and senescence. Proteomics studies leveraging mass spectrometry platforms from Thermo Fisher and bioinformatics pipelines from EMBL-EBI use U2OS lysates to profile post-translational modifications and signaling networks.

Genetic and molecular features

U2OS harbors an intact but sometimes functionally altered TP53 allele, making it a resource for dissecting p53-dependent transcriptional responses studied extensively in laboratories of Levine and Vousden. Its genome displays copy number alterations and structural rearrangements comparable to other sarcoma-derived genomes analyzed by consortia such as TCGA and ICGC. U2OS expresses telomerase-associated proteins and pathways investigated in studies by Harvard Medical School groups focusing on telomere biology and TERT regulation. Transcriptomic and epigenomic profiles from projects at ENCODE and Roadmap Epigenomics Project provide reference datasets for U2OS used in chromatin immunoprecipitation experiments targeting factors like H3K27me3 and transcription factors characterized by labs at Broad Institute.

Culture and maintenance

Standard culture conditions employ mediums supplied by vendors such as Gibco and supplements like fetal bovine serum procured through distributors linked to Sigma-Aldrich; many protocols follow guidelines published by ATCC and methods described in manuals from Cold Spring Harbor Laboratory Press. Maintenance includes routine mycoplasma testing often performed using kits from Lonza or PCR assays developed by groups at CDC. Transfection and viral transduction techniques adapted from protocols at Addgene and platforms used in facilities at Whitehead Institute enable genetic manipulation. Cryopreservation and authentication workflows rely on STR profiling services provided by commercial providers and reference databases curated by ATCC and university core facilities.

Limitations and biosafety concerns

As a cancer-derived, aneuploid human cell line, U2OS may not recapitulate normal osteoblast physiology, limiting translational extrapolation compared with primary cells from sources like NIH Clinical Center biobanks. Genetic drift and cross-contamination, issues documented in high-profile cases involving HeLa contamination, necessitate frequent authentication against databases maintained by ATCC and ICLAC. Biosafety practices follow institutional biosafety committees at universities such as MIT and Stanford University and guidelines from agencies like CDC and WHO for handling human-derived cell cultures; appropriate containment and training are required to mitigate risks of accidental exposure and environmental release. Potential misinterpretation of results due to cell line-specific idiosyncrasies has been highlighted by reviewers at journals including Nature Communications and PLoS Biology.

Category:Human cell lines